Targeting Huntington’s disease through histone deacetylases

Huntington’s disease (HD) is a debilitating neurodegenerative condition with significant burdens on both patient and healthcare costs. Despite extensive research, treatment options for patients with this condition remain limited. Aberrant post-translational modification (PTM) of proteins is emerging...

Descripción completa

Detalles Bibliográficos
Autor principal: Gray, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365382/
https://www.ncbi.nlm.nih.gov/pubmed/22704341
http://dx.doi.org/10.1007/s13148-011-0025-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365382/
https://www.ncbi.nlm.nih.gov/pubmed/22704341
http://dx.doi.org/10.1007/s13148-011-0025-7

Ejemplares similares